IRIS Accounts Production v24.3.2.46 SC630194 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6301942023-06-30SC6301942024-06-30SC6301942023-07-012024-06-30SC6301942022-06-30SC6301942022-07-012023-06-30SC6301942023-06-30SC630194ns15:Scotland2023-07-012024-06-30SC630194ns14:PoundSterling2023-07-012024-06-30SC630194ns10:Director12023-07-012024-06-30SC630194ns10:PrivateLimitedCompanyLtd2023-07-012024-06-30SC630194ns10:SmallEntities2023-07-012024-06-30SC630194ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-30SC630194ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-30SC630194ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-30SC630194ns10:FullAccounts2023-07-012024-06-30SC630194ns10:OrdinaryShareClass12023-07-012024-06-30SC630194ns10:OrdinaryShareClass22023-07-012024-06-30SC630194ns10:OrdinaryShareClass32023-07-012024-06-30SC630194ns10:Director22023-07-012024-06-30SC630194ns10:Director32023-07-012024-06-30SC630194ns10:RegisteredOffice2023-07-012024-06-30SC630194ns5:CurrentFinancialInstruments2024-06-30SC630194ns5:CurrentFinancialInstruments2023-06-30SC630194ns5:ShareCapital2024-06-30SC630194ns5:ShareCapital2023-06-30SC630194ns5:RetainedEarningsAccumulatedLosses2024-06-30SC630194ns5:RetainedEarningsAccumulatedLosses2023-06-30SC630194ns5:MotorVehicles2023-06-30SC630194ns5:ComputerEquipment2023-06-30SC630194ns5:MotorVehicles2023-07-012024-06-30SC630194ns5:ComputerEquipment2023-07-012024-06-30SC630194ns5:MotorVehicles2024-06-30SC630194ns5:ComputerEquipment2024-06-30SC630194ns5:MotorVehicles2023-06-30SC630194ns5:ComputerEquipment2023-06-30SC630194ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-30SC630194ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-30SC630194ns5:DeferredTaxation2023-06-30SC630194ns5:DeferredTaxation2023-07-012024-06-30SC630194ns5:DeferredTaxation2024-06-30SC630194ns10:OrdinaryShareClass12024-06-30SC630194ns10:OrdinaryShareClass22024-06-30SC630194ns10:OrdinaryShareClass32024-06-30
REGISTERED NUMBER: SC630194 (Scotland)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

Code Medical Ltd

Code Medical Ltd (Registered number: SC630194)






Contents of the Financial Statements
for the Year Ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Code Medical Ltd

Company Information
for the Year Ended 30 June 2024







DIRECTORS: Dr Colin P O'Leary
Mr C O'Leary
Dr Deirdre O'Driscoll





REGISTERED OFFICE: 25 Sandyford Place
Glasgow
G3 7NG





REGISTERED NUMBER: SC630194 (Scotland)





ACCOUNTANTS: Stevenson & Kyles
Chartered Accountants
25 Sandyford Place
Glasgow
G3 7NG

Code Medical Ltd (Registered number: SC630194)

Balance Sheet
30 June 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 16,341 20,022

CURRENT ASSETS
Debtors 5 3,400 28,381
Cash at bank 286,324 214,907
289,724 243,288
CREDITORS
Amounts falling due within one year 6 176,900 172,749
NET CURRENT ASSETS 112,824 70,539
TOTAL ASSETS LESS CURRENT
LIABILITIES

129,165

90,561

PROVISIONS FOR LIABILITIES 7 3,105 3,804
NET ASSETS 126,060 86,757

CAPITAL AND RESERVES
Called up share capital 8 200 200
Retained earnings 125,860 86,557
SHAREHOLDERS' FUNDS 126,060 86,757

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Code Medical Ltd (Registered number: SC630194)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 January 2025 and were signed on its behalf by:





Dr Colin P O'Leary - Director


Code Medical Ltd (Registered number: SC630194)

Notes to the Financial Statements
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

Code Medical Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Code Medical Ltd (Registered number: SC630194)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

2. ACCOUNTING POLICIES - continued

Grant income
Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 July 2023 35,594 - 35,594
Additions - 1,767 1,767
At 30 June 2024 35,594 1,767 37,361
DEPRECIATION
At 1 July 2023 15,572 - 15,572
Charge for year 5,006 442 5,448
At 30 June 2024 20,578 442 21,020
NET BOOK VALUE
At 30 June 2024 15,016 1,325 16,341
At 30 June 2023 20,022 - 20,022

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 3,400 28,381

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 15,011 21,149
Other creditors 161,889 151,600
176,900 172,749

Code Medical Ltd (Registered number: SC630194)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

7. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 3,105 3,804

Deferred
tax
£   
Balance at 1 July 2023 3,804
Provided during year (699 )
Balance at 30 June 2024 3,105

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary A £1 100 100
50 Ordinary B £1 50 50
50 Ordinary C £1 50 50
200 200

9. ULTIMATE CONTROLLING PARTY

The company is controlled by the O'Leary family.